Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

NCT05645744 · clinicaltrials.gov ↗

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Business Reasons

Conditions

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Chronic Lymphocytic Leukemia in Relapse
Small Lymphocytic Lymphoma, Relapsed
Waldenstrom's Macroglobulinemia Recurrent
Follicular B-cell Non-Hodgkin's Lymphoma
B-cell Lymphoma Refractory
Mantle Cell Lymphoma Recurrent
Hairy Cell Leukemia
Diffuse Large B Cell Lymphoma
Waldenstrom's Macroglobulinemia Refractory
Mantle Cell Lymphoma Refractory

Interventions

BIOLOGICAL: Prior MB-102 CAR-T cell investigational product.
BIOLOGICAL: Prior MB-106 CAR-T cell investigational product.

Sponsor

Mustang Bio